Research Diagnosis Related Groups (DRG) level mortality quality outcomes for Stanford Healthcare located at 300 Pasteur Dr, Stanford, CA, 94305 & includes data from NPIs 1265581086, 1871543215
Dexur analyzed Q3 2016 (July to September 2016) Medicare claims data to benchmark mortality rates for Stanford Healthcare compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
Total Hospitalizations (Jul 201 to Sep 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jul 201 to Sep 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 201 to Sep 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 2,391 | 2,276 | ||||||||||||||||||||||
Surgical | 1,178 | 1,134 | ||||||||||||||||||||||
Non Surgical | 1,213 | 1,142 | ||||||||||||||||||||||
Cardiovascular | 438 | 411 | ||||||||||||||||||||||
Orthopedics | 348 | 342 | ||||||||||||||||||||||
General Surgery | 341 | 315 | ||||||||||||||||||||||
General Medicine | 262 | 238 | ||||||||||||||||||||||
Gastroenterology & Endocrinology | 164 | 160 | ||||||||||||||||||||||
Oncology & Hematology | 148 | 142 | ||||||||||||||||||||||
Urology | 134 | 133 | ||||||||||||||||||||||
Neurology | 131 | 125 | ||||||||||||||||||||||
Pulmonology | 127 | 120 | ||||||||||||||||||||||
Spine | 120 | 118 | ||||||||||||||||||||||
Colorectal | 52 | 50 | ||||||||||||||||||||||
Psychiatry & Mental Disorders | 46 | 42 | ||||||||||||||||||||||
Obesity, Bariatric, Stomach & Duodenal | 39 | 39 | ||||||||||||||||||||||
Obstetrics & Gynecology | 32 | 32 |
Total Hospitalizations (Jul 201 to Sep 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jul 201 to Sep 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 201 to Sep 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||||||||||||||
DRG 220: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Endovascular Procedures | ||||||||||||||||||||||||
DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Heart Failure And Shock | ||||||||||||||||||||||||
DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Other Circulatory System Diagnoses | ||||||||||||||||||||||||
DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Peripheral Vascular Disorders | ||||||||||||||||||||||||
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||||||||||||||
DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Other Vascular Procedures | ||||||||||||||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||||||||||||||
DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Percutaneous Intracardiac Procedures | ||||||||||||||||||||||||
DRG 274: PERCUTANEOUS INTRACARDIAC PROCEDURES W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Syncope And Collapse | ||||||||||||||||||||||||
DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||||||||||||||
Aortic And Heart Assist Procedures | ||||||||||||||||||||||||
DRG 269: AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Acute Myocardial Infarction | ||||||||||||||||||||||||
Coronary Bypass | ||||||||||||||||||||||||
Permanent Cardiac Pacemaker Implant |
Total Hospitalizations (Jul 201 to Sep 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jul 201 to Sep 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 201 to Sep 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Revision Of Hip Or Knee Replacement | ||||||||||||||||||||||||
DRG 467: REVISION OF HIP OR KNEE REPLACEMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 468: REVISION OF HIP OR KNEE REPLACEMENT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||||||||||||||
DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||||||||||||||
DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Other Musculoskeletal System And Connective Tissue O.R. Procedures | ||||||||||||||||||||||||
Lower Extremity And Humerus Procedures Except Hip,Foot,Femur | ||||||||||||||||||||||||
Fractures Of Hip And Pelvis | ||||||||||||||||||||||||
DRG 536: FRACTURES OF HIP AND PELVIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy |
Total Hospitalizations (Jul 201 to Sep 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jul 201 to Sep 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 201 to Sep 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Craniotomy And Endovascular Intracranial Procedures | ||||||||||||||||||||||||
DRG 027: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 026: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 025: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Major Chest Procedures | ||||||||||||||||||||||||
DRG 164: MAJOR CHEST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Pancreas, Liver And Shunt Procedures | ||||||||||||||||||||||||
DRG 406: PANCREAS, LIVER AND SHUNT PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Wound Debridement And Skin Graft Except Hand, For Musculoskeletal And Connective Tissue Disorders | ||||||||||||||||||||||||
DRG 464: WOUND DEBRIDEMENT AND SKIN GRAFT EXCEPT HAND FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Tracheostomy For Face, Mouth And Neck Diagnoses Or Laryngectomy | ||||||||||||||||||||||||
Extracranial Procedures | ||||||||||||||||||||||||
Extensive O.R. Procedure Unrelated To Principal Diagnosis |
Total Hospitalizations (Jul 201 to Sep 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jul 201 to Sep 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 201 to Sep 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||||||||||||||
Signs And Symptoms | ||||||||||||||||||||||||
DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Cellulitis | ||||||||||||||||||||||||
DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Complications Of Treatment | ||||||||||||||||||||||||
Postoperative And Post-Traumatic Infections |
Total Hospitalizations (Jul 201 to Sep 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jul 201 to Sep 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 201 to Sep 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
G.I.Hemorrhage | ||||||||||||||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
G.I. Obstruction | ||||||||||||||||||||||||
Other Digestive System Diagnoses | ||||||||||||||||||||||||
Disorders Of Biliary Tract |
Total Hospitalizations (Jul 201 to Sep 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jul 201 to Sep 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 201 to Sep 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||||||||||||||
DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | ||||||||||||||||||||||||
DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Lymphoma And Non-Acute Leukemia |
Total Hospitalizations (Jul 201 to Sep 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jul 201 to Sep 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 201 to Sep 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Renal Failure | ||||||||||||||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Other Kidney And Urinary Tract Diagnoses | ||||||||||||||||||||||||
DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Kidney And Urinary Tract Infections | ||||||||||||||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Kidney And Ureter Procedures | ||||||||||||||||||||||||
Major Male Pelvic Procedures | ||||||||||||||||||||||||
Major Bladder Procedures |
Total Hospitalizations (Jul 201 to Sep 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jul 201 to Sep 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 201 to Sep 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||||||||||||||
DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||||||||||||||
Other Disorders Of Nervous System | ||||||||||||||||||||||||
Traumatic Stupor And Coma, Coma < 1 Hour | ||||||||||||||||||||||||
Seizures | ||||||||||||||||||||||||
Degenerative Nervous System Disorders | ||||||||||||||||||||||||
Cranial And Peripheral Nerve Disorders |
Total Hospitalizations (Jul 201 to Sep 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jul 201 to Sep 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 201 to Sep 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Simple Pneumonia And Pleurisy | ||||||||||||||||||||||||
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Respiratory Infections And Inflammations | ||||||||||||||||||||||||
DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Pulmonary Embolism | ||||||||||||||||||||||||
Chronic Obstructive Pulmonary Disease |
Total Hospitalizations (Jul 201 to Sep 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jul 201 to Sep 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 201 to Sep 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Spinal Fusion Except Cervical | ||||||||||||||||||||||||
DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Back And Neck Procedures, Except Spinal Fusion, Or Disc Devices/Neurostimulators | ||||||||||||||||||||||||
Cervical Spinal Fusion | ||||||||||||||||||||||||
Combined Anterior/Posterior Spinal Fusion | ||||||||||||||||||||||||
DRG 454: COMBINED ANTERIOR/POSTERIOR SPINAL FUSION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Spinal Fusion Except Cervical With Spinal Curvature / Malignancy / Infection Or Extensive Fusions |
Total Hospitalizations (Jul 201 to Sep 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jul 201 to Sep 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 201 to Sep 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures | ||||||||||||||||||||||||
DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jul 201 to Sep 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jul 201 to Sep 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 201 to Sep 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychoses | ||||||||||||||||||||||||
DRG 885: PSYCHOSES |
Total Hospitalizations (Jul 201 to Sep 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | California Total Hospitalizations (Jul 201 to Sep 2016) | California Total Hospitalizations After Exclusion | California Total Users | California In Hospital Mortality Rate (%) | California 30 Day Mortality Rate (%) | California 60 Day Mortality Rate (%) | California 90 Day Mortality Rate (%) | California 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 201 to Sep 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stomach, Esophageal And Duodenal Procedures | ||||||||||||||||||||||||
DRG 327: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) |